Clinical Trial Update: Efficacy and Safety of Viusid in Patients With Nonalcoholic Steatohepatitis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated the efficacy and safety of Viusid in patients with nonalcoholic steatohepatitis. The study has completed, with results updated thereaf…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Steatohepatitis

Drugs mentioned

• Viusid

Snippet

Sponsor: Catalysis SL | Conditions: Nonalcoholic Steatohepatitis | Phase 3 | Status: COMPLETED